Financhill
Back

Grifols SA 10K Form

Buy
63

GRFS
Grifols SA

Last Price:
$8.92
Seasonality Move:
3.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GRFS News And Ratings

See the #1 stock for the next 7 days that we like better than GRFS

GRFS Financial Statistics

Sales & Book Value

Annual Sales: $7.8B
Cash Flow: $250.8M
Price / Cash Flow: 7.77
Annual Sales: $8.95
Price / Book: 2.61

Profitability

EPS (TTM): 0.61420
Net Income (TTM): $511.2M
Gross Margin: $2.8B
Return on Equity: 5.73%
Return on Assets: 2.24%

Grifols SA Earnings Forecast

Key Grifols SA Financial Ratios

  • The Gross Profit Margin over the past 23 years for GRFS is 36.46%.
  • The Selling, General & Administrative Expenses for GRFS have been equal to 17.40% of Gross Profit Margin.
  • The Research & Development expenses have been 4.59% of Revenue.
  • The Interest Expense is 335.88% of Operating Income.
  • The Net Earning history of GRFS is 2.95% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 8 years.

Grifols SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GRFS
CUSIP: 398438
Website: grifols.com

Debt

Debt-to-Equity Ratio: 1.87
Current Ratio: 2.48
Quick Ratio: 0.8

Price-to-Earnings

Trailing P/E Ratio: 35.47
Forward P/E Ratio: 6.97

GRFS Technical Analysis vs Fundamental Analysis

Buy
63
Grifols SA (GRFS) is a Buy

Is Grifols SA a Buy or a Sell?

  • Grifols SA stock is rated a Buy
    The current Grifols SA [GRFS] share price is $8.85. The Score for GRFS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.